Current clinical trials

A study to evaluate the safety and effectiveness of a new combined treatment in companion dogs diagnosed with malignant melanoma

Study to develop a reliable, minimally-invasive blood test for early detection of canine osteosarcoma.

Blood sampling to determine new approaches to diagnosis, screening and potential ability to treat or prevent cancer in dogs

Identifying and exploring treatments for canine hemangiosarcoma

A minimally invasive blood sampling study to identify dogs at high risk of developing Diffuse Large B-cell Lymphoma (DLBCL)

A study for client-owned dogs with metastatic or inoperable sarcomas to examine the safety and efficacy of a new combination therapy

Novel adeno-associated virus (AAV) vaccine for dogs with malignant oral melanoma

A double-blinded study to investigate the safety and efficacy of an investigational monoclonal antibody to aid in the treatment of malignant oral melanoma in dogs

This study hopes to understand how a new combination immunotherapy works and to determine if it is effective in the treatment for dogs with relapsed and refractory aggressive lymphoma. There are two separate aims for the study using VSV (vesicular stomatitis virus) and ONIx (onco-immune accelerator) both individually and together as treatments. 

Blood sampling study of dogs to develop test for early detection of canine osteosarcoma.

Study for dogs to test eBAT prevention of cancer

Veterinary clinical trial for dogs with soft tissue sarcoma or bone sarcoma to study a TriKE immunotherapy